Gavin Bendle

2.2k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Gavin Bendle is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Gavin Bendle has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Immunology and 8 papers in Genetics. Recurrent topics in Gavin Bendle's work include CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (9 papers). Gavin Bendle is often cited by papers focused on CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (9 papers). Gavin Bendle collaborates with scholars based in United Kingdom, Netherlands and Germany. Gavin Bendle's co-authors include Ton N. Schumacher, Carsten Linnemann, Hans J. Stauss, John B.A.G. Haanen, Shao‐An Xue, Laura Bies, Angelika Holler, Wolfgang Uckert, Moniek A. de Witte and Ji‐Ying Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Gavin Bendle

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

2018 373 citations Wouter Scheper, Sander Kelderman et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gavin Bendle United Kingdom	17	1.2k	1.0k	397	342	120	29	1.5k
Thomas E. Shelton United States	8	1.4k 1.2×	1.2k 1.2×	282 0.7×	359 1.0×	91 0.8×	8	1.6k
Giacomo Oliveira Italy	14	854 0.7×	802 0.8×	237 0.6×	405 1.2×	182 1.5×	26	1.4k
Michelle M. Langhan United States	8	1.6k 1.4×	1.3k 1.3×	291 0.7×	344 1.0×	97 0.8×	10	1.9k
Yukimi Sakoda Japan	17	1.2k 1.1×	898 0.9×	269 0.7×	361 1.1×	389 3.2×	27	1.7k
Raquel Gomez-Eerland Netherlands	10	913 0.8×	907 0.9×	142 0.4×	426 1.2×	82 0.7×	14	1.4k
Mary A. Black United States	11	1.1k 1.0×	681 0.7×	295 0.7×	478 1.4×	206 1.7×	16	1.3k
Elixabet Bolaños Spain	19	887 0.8×	972 1.0×	146 0.4×	290 0.8×	98 0.8×	33	1.4k
Andras Heczey United States	19	1.5k 1.3×	898 0.9×	378 1.0×	527 1.5×	322 2.7×	49	2.1k
Qunrui Ye United States	15	1.4k 1.2×	1.0k 1.0×	334 0.8×	445 1.3×	303 2.5×	17	2.0k
Jonathan Treisman United States	14	675 0.6×	602 0.6×	243 0.6×	425 1.2×	93 0.8×	31	1.1k

Countries citing papers authored by Gavin Bendle

Since Specialization

Citations

This map shows the geographic impact of Gavin Bendle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Bendle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Bendle more than expected).

Fields of papers citing papers by Gavin Bendle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Bendle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Bendle. The network helps show where Gavin Bendle may publish in the future.

Co-authorship network of co-authors of Gavin Bendle

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Bendle. A scholar is included among the top collaborators of Gavin Bendle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Bendle. Gavin Bendle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Jennifer, Xiangjun Kong, Paula Kroon, et al.. (2024). Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition.. Journal of Clinical Oncology. 42(16_suppl). 2560–2560.

Ma, Jennifer, Xiangjun Kong, Paula Kroon, et al.. (2024). Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition.. Journal of Clinical Oncology. 42(16_suppl). e14533–e14533. 2 indexed citations

Santegoets, Saskia J., Marij J.P. Welters, Bianca Weißbrich, et al.. (2022). The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer. Cancer Immunology Immunotherapy. 72(6). 1553–1565. 9 indexed citations

Croft, Nathan P., Anthony W. Purcell, Carsten Linnemann, et al.. (2018). Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies. Journal for ImmunoTherapy of Cancer. 6(1). 70–70. 26 indexed citations

Scheper, Wouter, Sander Kelderman, Lorenzo F. Fanchi, et al.. (2018). Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nature Medicine. 25(1). 89–94. 373 indexed citations breakdown →

Mussai, Francis, Sharon A. Egan, Stuart Hunter, et al.. (2015). Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. Cancer Research. 75(15). 3043–3053. 84 indexed citations

Gilham, David E., John Anderson, John S. Bridgeman, et al.. (2015). Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015. Human Gene Therapy. 26(5). 276–285. 15 indexed citations

Bunse, Mario, Gavin Bendle, Carsten Linnemann, et al.. (2014). RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer. Molecular Therapy. 22(11). 1983–1991. 52 indexed citations

Linnemann, Carsten, Ton N. Schumacher, & Gavin Bendle. (2011). T-Cell Receptor Gene Therapy: Critical Parameters for Clinical Success. Journal of Investigative Dermatology. 131(9). 1806–1816. 31 indexed citations

10.

Leeuwen, Anne C. van, Tessa Buckle, Gavin Bendle, et al.. (2011). Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model. Journal of Biomedical Optics. 16(1). 16004–16004. 57 indexed citations

11.

Bendle, Gavin, Carsten Linnemann, Anna I. Hooijkaas, et al.. (2010). Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nature Medicine. 16(5). 565–570. 324 indexed citations

12.

Wright, Graham P., Clare A. Notley, Shao‐An Xue, et al.. (2009). Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proceedings of the National Academy of Sciences. 106(45). 19078–19083. 177 indexed citations

13.

Bendle, Gavin, John B.A.G. Haanen, & Ton N. Schumacher. (2009). Preclinical development of T cell receptor gene therapy. Current Opinion in Immunology. 21(2). 209–214. 39 indexed citations

14.

Witte, Moniek A. de, Gavin Bendle, Marly D. van den Boom, et al.. (2008). TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation. The Journal of Immunology. 181(4). 2563–2571. 36 indexed citations

15.

Xue, Shao‐An, Gavin Bendle, Angelika Holler, & Hans J. Stauss. (2008). Generation and characterization of transgenic mice expressing a T‐cell receptor specific for the tumour‐associated antigen MDM2. Immunology. 124(3). 315–321. 2 indexed citations

16.

Witte, Moniek A. de, Annelies Jorritsma, Andrew Kaiser, et al.. (2008). Requirements for Effective Antitumor Responses of TCR Transduced T Cells. The Journal of Immunology. 181(7). 5128–5136. 46 indexed citations

17.

Bendle, Gavin, Shao‐An Xue, Angelika Holler, & Hans J. Stauss. (2007). A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function. PLoS ONE. 2(4). e353–e353. 7 indexed citations

18.

McNicol, Anne‐Marie, Gavin Bendle, Angelika Holler, et al.. (2007). CD8α/α homodimers fail to function as co‐receptor for a CD8‐dependent TCR. European Journal of Immunology. 37(6). 1634–1641. 25 indexed citations

19.

Stauss, Hans J., et al.. (2004). Exploiting alloreactivity for tumour immunotherapy. Vox Sanguinis. 87(s2). 227–229. 6 indexed citations

20.

Gao, Li, Roopinder Gillmore, Gavin Bendle, et al.. (2004). WT1-targeted immunotherapy of leukaemia. Blood Cells Molecules and Diseases. 33(3). 288–290. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact